Non-medical switching: Looming Rx care obstacle?
As anyone reading the headlines these days can see, the outlook for health care coverage is … well, a big…
January 19, 2017 by CDR Blog and Chain Drug Review CDR Blog, Opinion
As anyone reading the headlines these days can see, the outlook for health care coverage is … well, a big…
January 18, 2017 by Scott Melville and Chain Drug Review Leading Headlines, Opinion
The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome…
January 17, 2017 by Steve Anderson and Chain Drug Review Opinion
I will spare you the introductory paragraph that attempts eloquence. Let’s get right to the point. In NACDS’ view, 2017…
January 16, 2017 by Jeffrey Woldt and Chain Drug Review 2017, Issue 01-16-2017, Issues, Leading Headlines, Opinion
After stumbling out of the gate early this month with an ill-conceived bid to hamstring the Office of Congressional Ethics…
January 16, 2017 by David Pinto and Chain Drug Review 2017, Issue 01-16-2017, Issues, Opinion
Going into the new year, several key personnel questions await answers, foremost among them the age-old problem of determining who,…
January 4, 2017 by Dan Leonard and Chain Drug Review Opinion
For the past two years, organizations in the private and public sectors have been working to develop tools to support…
January 3, 2017 by David Farber and Chain Drug Review 2017, Issue 01-02-2017, Issues, Leading Headlines, Opinion
The January 20, 2017, inauguration of President Trump as the nation’s 45th president is certain to bring with it changes…
January 2, 2017 by Jeffrey Woldt and Chain Drug Review 2017, Issue 01-02-2017, Issues, Opinion
The agreement struck last month for the sale of 865 Rite Aid Corp. drug stores to Fred’s Inc. is a…